Metastatic Non-Squamous Non-Small Cell Lung Carcinoma

Known as: Metastatic Non-Squamous Non-Small Cell Lung Cancer 
A non-squamous non-small cell carcinoma that arises from the lung and has metastasized to another anatomic site.
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2017
012320092017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
The concept of exploiting the host’s immune system to fight cancer relies on the concept of tumour immune surveillance, the… (More)
Is this relevant?
2017
2017
Delta-like ligand 4-Notch (DLL4-Notch) signaling contributes to the maintenance of chemotherapy-resistant cancer stem cells and… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2015
2015
Toxic epidermal necrolysis (TEN) is a rare acute life-threatening mucocutaneous disorder that is mostly drug-related (80%-95… (More)
Is this relevant?
2015
2015
OBJECTIVES To compare the activity and tolerance of the consecutive administration of four active chemotherapeutic agents in… (More)
Is this relevant?
2014
2014
INTRODUCTION Pemetrexed and erlotinib have been approved as second-line monotherapy for locally advanced or metastatic non-small… (More)
Is this relevant?
2014
2014
Background:This study evaluated the efficacy and safety of ziv-aflibercept in combination with cisplatin and pemetrexed in non… (More)
  • table 2
  • table 1
  • figure 1
  • table 3
Is this relevant?
2014
2014
BACKGROUND In the Iressa Pan-ASia Study (IPASS), gefitinib claimed improved progression-free survival (PFS) versus carboplatin… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2012
2012
EGFR tyrosine kinase inhibitors (EGFR-TKIs) are recommended as first-line therapy in patients with advanced, recurrent, or… (More)
Is this relevant?
Review
2011
Review
2011
Pemetrexed (Alimta®) is a multitargeted antifolate drug approved as a single agent or in combination with cisplatin for the… (More)
Is this relevant?
2009
2009
e19023 Background: Bevacizumab (B), in addition to platinum-based chemotherapy, is indicated for 1st-line treatment of p with… (More)
Is this relevant?